ReviewJournal of the American Heart Association2026
Multimodality Approach to Coronary Ischemic Testing in Pediatric Patients: A Scientific Statement From the American Heart Association.
Review in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Coronary Artery Aneurysms and Dilation in Children With RASopathies.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As new research reveals the value of provocative and ischemic coronary testing in various acquired and congenital coronary issues in children, an unmet need for targeted and thoughtful provocative ischemic testing emerges as a high priority for our field. A number of evidence-based guidelines and scientific statements for conditions including Kawasaki disease, multisystem inflammatory syndrome in children associated with coronary aneurysms, anomalous aortic origin of the coronary arteries, cardiac allograft vasculopathy, and surgically repaired congenital heart disease involving coronary artery manipulation now recommend provocative ischemic testing in children. The strengths and limitations of various testing modalities and provocative agents are explored, including the evidence for use in children. In addition, evidence-based adaptations and recommendations for optimizing use of these technologies in children are noted. The pediatric cardiac imaging community requires more information to understand appropriate use of existing provocative ischemic modalities and to help develop the technology for future use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.